Abstract
Twenty-four patients receiving combination chemotherapy including cisplatin at a dosage of 50 mg/m2 were entered on this antiemetic randomized open cross-over study. High-dose dexamethasone (DXM) (regimen A) was compared with the combination of DXM and high doses of metoclopramide (MCP) (regimen B). Five patients (20%) treated with regimen A and 13 (54%) treated with regimen B suffered neither hausea nor vomiting (P
Original language | English |
---|---|
Pages (from-to) | 235-237 |
Number of pages | 3 |
Journal | Cancer Chemotherapy and Pharmacology |
Volume | 13 |
Issue number | 3 |
DOIs | |
Publication status | Published - Oct 1984 |
ASJC Scopus subject areas
- Pharmacology
- Oncology
- Cancer Research